34% average premium hike for silver plans on ACA exchanges

The most popular health plans on the Affordable Care Act (ACA)’s exchanges, silver-level plans, will require 34 percent higher premiums on average in 2018, according to an analysis from Avalere Health. The average hike for the second-lowest-priced silver plans, often considered the benchmark for the exchanges, will be 38 percent.

Many ACA enrollees will be shielded from the hikes by the law’s premium support subsidies. Unsubsidized enrollees could find less drastic hikes with bronze or gold plans, which will see premium hikes of 18 percent and 16 percent, respectively.

“Plans are raising premiums in 2018 to account for market uncertainty and the federal government’s failure to pay for cost-sharing reductions,” Caroline Pearson, senior vice president at Avalere, said in a statement. “These premium increases may allow insurers to remain in the market and enrollees in all regions to have access to coverage.”

The biggest jump in silver plan premiums is in Iowa, where monthly prices will rise by an average of 69 percent. In three states, the average premium decreased: Alaska (22 percent drop), Arizona (6 percent drop) and North Dakota (4 percent drop).

Among all metal tiers, the average monthly premium has increased substantially since 2015. Bronze plan rates went from $373 per month in 2015 to $561. Silver plans rose from $453 to $743. Gold plans went from $530 to $831. Platinum plans—the least popular ACA plans which cover 90 percent of customers’ health costs but are chosen by fewer than 1 percent of enrollees—have seen premiums increase from $645 in 2015 to $1,125 in 2018.

The Congressional Budget Office had predicted another double-digit hike in premiums ahead of the Nov. 1 start date for open enrollment on account of uncertainty among insurers that cost-sharing reduction subsidies would continue to be paid—a fear which was realized when President Donald Trump halted the payments in October. Sens. Lamar Alexander, R-Tennessee and Patty Murray, D-Washington, have proposed a plan to alleviate some of the 2018 hikes by funding the CSRs for two years, with rebates from insurers included to gain back portions of the premium hikes which were based on CSRs being pulled.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.